← Leaderboards
Anbu Devasahayam
$5,038,795
Attributed
$5,038,795
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$5,038,795 · 1
By mechanism
N01$5,038,795 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Biological Products”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Christina Millin · Rho Federal Systems Division, Inc.$23,515,000
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin V Grimes · Stanford University$14,783,804
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
Research focus
Biological ProductsClinical ResearchClinical TrialsContractsEquipment And Supply InventoriesFundingInfectious Disease TreatmentProgramsScheduleServicesVaccine TrialNational Institute Of Allergy And Infectious DiseasePharmacologic SubstancePlacebosPreventionProduct LabelingManufactureInvestigationRadiationNuclear Countermeasure
Grant awards (4)
NIAID DAIT CLINICAL PRODUCTS CENTER (CPC)$1,150,978
N01 · FY2025 · AI · contact PI
NIAID DAIT CLINICAL PRODUCTS CENTER (CPC)$744,420
N01 · FY2024 · AI · contact PI
NIAID DAIT CLINICAL PRODUCTS CENTER (CPC)$2,050,316
N01 · FY2023 · AI · contact PI
NIAID DAIT CLINICAL PRODUCTS CENTER (CPC) for Studies of Radiation/Nuclear Countermeasures Research$1,093,081
N01 · FY2022 · AI · contact PI